Conexeu Sciences Inc. Common Stock (CNXU)
Stock · NASDAQ · Health Care
$3.06as of 10/16/2026
Price chart
About CNXU
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volum…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Website
- www.conexeu.com
Fundamentals
- 1-day range
- $3.05$4
- Market cap
- $226.64M
- P/E (trailing)
- —
- P/E (forward)
- -5.77
- EPS (trailing)
- $-0.67
- Dividend yield
- —
- Beta
- -1.24
- Avg. volume
- 235.0K
52-week range
$3.05$18.79
Forecasts
1 analyst ratings
Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$20
+553.6%
Median
$20
+553.6%
Low
$20
+553.6%
Conexeu Sciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CNXUConexeu Sciences Inc. Common Stock$3.06▼ 22.53%Market cap $226.64MP/E —$3.05$18.79
- HDSNHudson Technologies Inc. Common Stock$5.01▼ 0.60%Market cap $237.90MP/E 23.59$4.64$9.65
- INGNInogen Inc Common Stock$6.25▼ 0.71%Market cap $175.71MP/E —$5.05$9.13
- ASLEAerSale Corporation Common Stock$4.76▲ 1.49%Market cap $297.69MP/E 26.24$4.89$8.58
- BOOMDMC Global Inc. Common Stock$5.33▲ 1.72%Market cap $154.47MP/E —$4.69$9.2
- ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares$2.08▼ 3.48%Market cap $150.59MP/E 110.49$1.53$8.48
- OFLXOmega Flex Inc. Common Stock$25.62▲ 0.12%Market cap $312.42MP/E 22.03$24.75$37.92
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CNXU Conexeu Sciences Inc. Common Stock | $226.64M | — | $3.06 | ▼ 22.53% | $3.05$18.79 |
| HDSN Hudson Technologies Inc. Common Stock | $237.90M | 23.59 | $5.01 | ▼ 0.60% | $4.64$9.65 |
| INGN Inogen Inc Common Stock | $175.71M | — | $6.25 | ▼ 0.71% | $5.05$9.13 |
| ASLE AerSale Corporation Common Stock | $297.69M | 26.24 | $4.76 | ▲ 1.49% | $4.89$8.58 |
| BOOM DMC Global Inc. Common Stock | $154.47M | — | $5.33 | ▲ 1.72% | $4.69$9.2 |
| ZJYL JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares | $150.59M | 110.49 | $2.08 | ▼ 3.48% | $1.53$8.48 |
| OFLX Omega Flex Inc. Common Stock | $312.42M | 22.03 | $25.62 | ▲ 0.12% | $24.75$37.92 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Let's have a look at the top gainers and losers in the middle of the day of today's session.ChartMill · 10/9/2026
- Conexeu Sciences shares are trading higher after the company announced it advanced Ten Minute Tissue towards a planned FDA 510(k) submission.Benzinga · 10/6/2026
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · 10/6/2026
- Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) SubmissionYahoo · 10/6/2026
- Conexeu Sciences Issues Update On Regulatory And Manufacturing Program Supporting Planned FDA 510(k) Premarket Notification For Ten Minute Tissue, Lead Wound Care Device CandidateBenzinga · 10/6/2026
Insider Activity
Insider Actions →Acquired
2.82M
Disposed
202.5K
- Bogart David Robert · September 25, 2026 · Option Exercise750.0K @ $0.001
- Sharpe Jeffrey Nathan · September 14, 2026 · Option Exercise500.0K @ $0.001
- Purcell Lynn Sebastian · September 4, 2026 · X217.6K @ $2.3
- Purcell Lynn Sebastian · June 18, 2026 · Option Exercise202.5K @ $0.8
- Purcell Lynn Sebastian · June 18, 2026 · Buy202.5K @ $0.8
- Wright Michael G. · June 18, 2026 · Option Exercise250.0K @ $0.001
- Wright Michael G. · May 26, 2026 · Option Exercise400.0K @ $0.001
- Sharpe Jeffrey Nathan · May 22, 2026 · Option Exercise500.0K @ $0.001
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
CNXU Provides Update on FDA 510(k) Program for Wound Care Device
Conexeu Sciences released an update describing its regulatory and manufacturing program that supports a planned FDA 510(k) premarket notification for a ten‑minute tissue, lead wound‑care device candidate. The announcement signals progress toward filing the notification and may affect the timeline for potential market entry. The stock is currently near a support level of $9.62 and has an RSI of 31.4, suggesting limited momentum.
CNXU Provides Update on FDA 510(k) Program for Wound Care Device. Conexeu Sciences released an update describing its regulatory and manufacturing program that supports a planned FDA 510(k) premarket notification for a ten‑minute tissue, lead wound‑care device candidate. The announcement signals progress toward filing the notification and may affect the timeline for potential market entry. The stock is currently near a support level of $9.62 and has an RSI of 31.4, suggesting limited momentum.